Pfizer  logo

Pfizer PFE

$ 27.57 0.97%

Annual report 2025
added 02-26-2026

report update icon

Country

usaUSA

IPO year

-

Industry

Biotechnology

Stock Exchange

NYSESPB

Shares

5.68 B

Market Cap[1]

$ 157 B

EBITDA (LTM)

$ 6.66 B

P/E (LTM)

11.3

P/S (LTM)

2.5

EPS (LTM)

2.44

Pfizer is a global pharmaceutical company that has been in operation for over 170 years. The company is headquartered in New York City and has a presence in over 150 countries worldwide. Pfizer's mission is to discover, develop, and deliver innovative medicines and vaccines that improve the lives of people around the world.

Pfizer has a diverse portfolio of products that address a range of health conditions, including cardiovascular disease, oncology, inflammation, immunology, and rare diseases. Some of the company's most well-known products include Lipitor, Viagra, and Lyrica.

In addition to developing new treatments, Pfizer is committed to improving access to healthcare for people in need. The company has established partnerships with governments, non-governmental organizations, and healthcare providers to expand access to its medicines and vaccines.

Pfizer is also dedicated to sustainability and reducing its environmental impact. The company has set ambitious goals to reduce greenhouse gas emissions, water consumption, and waste generation across its operations.

As a leading pharmaceutical company, Pfizer is constantly innovating and adapting to meet the changing needs of patients and healthcare providers. With a focus on research and development, access to healthcare, and sustainability, Pfizer is poised to continue making a positive impact on global health for years to come.

Other stocks of industry "Biotechnology"

Issuer Price % 24h Market Cap Exchange Country
MorphoSys AG MorphoSys AG
MOR
- 2.43 % $ 254 M Nasdaq Global Select Market germanyGermany
ARCA biopharma ARCA biopharma
ABIO
- 1052.0 % $ 415 M Nasdaq Capital Market usaUSA
Aeterna Zentaris Aeterna Zentaris
AEZS
- 5.93 % $ 314 M Nasdaq Capital Market canadaCanada
AgeX Therapeutics AgeX Therapeutics
AGE
- -10.17 % $ 12.2 K NYSE American usaUSA
Aeglea BioTherapeutics Aeglea BioTherapeutics
AGLE
- - $ 1.01 B Nasdaq Global Market usaUSA
AIkido Pharma AIkido Pharma
AIKI
- 1.93 % $ 17.4 M Nasdaq Capital Market usaUSA
Akouos Akouos
AKUS
- 0.23 % $ 488 M Nasdaq Global Select Market usaUSA
Akero Therapeutics Akero Therapeutics
AKRO
- - $ 3.67 B Nasdaq Global Select Market,SPB usaUSA
I-Mab I-Mab
IMAB
- - $ 866 M Nasdaq Global Select Market chinaChina
Amarin Corporation plc Amarin Corporation plc
AMRN
$ 14.67 -0.07 % $ 6.09 B Nasdaq Global Market irlandaIrlanda
Alexion Pharmaceuticals, Inc. Alexion Pharmaceuticals, Inc.
ALXN
- - $ 40.3 B Nasdaq Global Select Market usaUSA
Genfit SA Genfit SA
GNFT
- 2.54 % $ 160 B Nasdaq Global Select Market franceFrance
Albireo Pharma Albireo Pharma
ALBO
- -0.23 % $ 916 M Nasdaq Capital Market usaUSA
Biophytis SA Biophytis SA
BPTS
- -13.47 % $ 169 M Nasdaq Capital Market franceFrance
Aileron Therapeutics Aileron Therapeutics
ALRN
- 10.36 % $ 9.8 M Nasdaq Global Select Market usaUSA
Aptinyx Aptinyx
APTX
- -39.0 % $ 4.57 M Nasdaq Global Select Market usaUSA
Midatech Pharma plc Midatech Pharma plc
MTP
- -18.52 % $ 27.3 M Nasdaq Global Select Market britainBritain
EyeGate Pharmaceuticals, Inc. EyeGate Pharmaceuticals, Inc.
EYEG
- -1.52 % $ 24.7 M Nasdaq Capital Market usaUSA
Arena Pharmaceuticals Arena Pharmaceuticals
ARNA
- -6.81 % $ 3.04 B Nasdaq Global Select Market,SPB usaUSA
Applied Genetic Technologies Corporation Applied Genetic Technologies Corporation
AGTC
- - $ 26.5 M Nasdaq Global Select Market usaUSA
Avenue Therapeutics Avenue Therapeutics
ATXI
- -52.27 % $ 4.45 M Nasdaq Global Select Market usaUSA
Ayala Pharmaceuticals Ayala Pharmaceuticals
AYLA
- - $ 7.46 M Nasdaq Global Market israelIsrael
Atreca Atreca
BCEL
- -11.76 % $ 5.79 M Nasdaq Global Select Market usaUSA
Acorda Therapeutics Acorda Therapeutics
ACOR
- -24.86 % $ 820 K Nasdaq Global Select Market usaUSA
bluebird bio bluebird bio
BLUE
- - $ 546 M Nasdaq Global Select Market,SPB usaUSA
Acasti Pharma Acasti Pharma
ACST
- 4.01 % $ 150 M Nasdaq Capital Market canadaCanada
Институт стволовых клеток человека Институт стволовых клеток человека
ISKJ
- - - MOEX russiaRussia
Cabaletta Bio Cabaletta Bio
CABA
$ 2.82 1.44 % $ 283 M Nasdaq Global Select Market usaUSA
Avid Bioservices Avid Bioservices
CDMO
- - $ 789 M Nasdaq Capital Market usaUSA
Adverum Biotechnologies Adverum Biotechnologies
ADVM
- - $ 86.2 M Nasdaq Global Market usaUSA
Acer Therapeutics Acer Therapeutics
ACER
- 2.71 % $ 14 M Nasdaq Capital Market usaUSA
Advaxis Advaxis
ADXS
- -9.65 % $ 45.9 M Nasdaq Capital Market usaUSA
Autolus Therapeutics plc Autolus Therapeutics plc
AUTL
$ 1.29 -3.01 % $ 329 M Nasdaq Global Select Market britainBritain
CEL-SCI Corporation CEL-SCI Corporation
CVM
$ 3.47 -1.7 % $ 221 M NYSE American,SPB usaUSA
BeiGene, Ltd. BeiGene, Ltd.
BGNE
- 0.49 % $ 251 B Nasdaq Global Select Market cayman-islandsCayman-islands
Denali Therapeutics Denali Therapeutics
DNLI
$ 19.74 -12.17 % $ 3.25 B Nasdaq Global Select Market,SPB usaUSA
BioDelivery Sciences International BioDelivery Sciences International
BDSI
- -4.8 % $ 255 M Nasdaq Global Select Market usaUSA
Cara Therapeutics Cara Therapeutics
CARA
- -3.03 % $ 260 M Nasdaq Global Market,SPB usaUSA
ChemoCentryx ChemoCentryx
CCXI
- - $ 3.74 B Nasdaq Global Select Market,SPB usaUSA
Enlivex Therapeutics Ltd. Enlivex Therapeutics Ltd.
ENLV
$ 1.09 -9.17 % $ 22.4 M Nasdaq Capital Market israelIsrael
Enochian Biosciences Enochian Biosciences
ENOB
- - $ 40.5 M Nasdaq Capital Market usaUSA
CureVac N.V. CureVac N.V.
CVAC
- - $ 867 M Nasdaq Global Market germanyGermany
Equillium Equillium
EQ
$ 2.06 - $ 118 M Nasdaq Global Market usaUSA
Esperion Therapeutics Esperion Therapeutics
ESPR
$ 2.85 3.26 % $ 592 M Nasdaq Global Market,SPB usaUSA
Eton Pharmaceuticals Eton Pharmaceuticals
ETON
$ 23.45 -1.64 % $ 631 M Nasdaq Global Market usaUSA
China SXT Pharmaceuticals China SXT Pharmaceuticals
SXTC
$ 1.32 -5.2 % $ 1.88 M Nasdaq Global Select Market chinaChina
Bellerophon Therapeutics Bellerophon Therapeutics
BLPH
- -74.18 % $ 955 K Nasdaq Capital Market usaUSA
CRISPR Therapeutics AG CRISPR Therapeutics AG
CRSP
$ 47.55 0.98 % $ 4.28 B Nasdaq Global Market,SPB schweizSchweiz
Arbutus Biopharma Corporation Arbutus Biopharma Corporation
ABUS
$ 4.45 -1.77 % $ 853 M Nasdaq Global Select Market canadaCanada
Allakos Allakos
ALLK
- - $ 28.6 M Nasdaq Global Select Market,SPB usaUSA

References

  1. Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.